Navigation Links
Rusk experts present at American Association of Physical Medicine and Rehabilitation meeting
Date:11/16/2011

Experts from Rusk Institute of Rehabilitation Medicine at NYU Langone Medical Center will present research and clinical insight into complex medical rehabilitation, the treatment of traumatic brain injuries and the integration of handheld technologies into practice management at the American Association of Physical Medicine and Rehabilitation (AAPM&R) Annual Meeting in Orlando, November 17-20, 2011. Experts will be available to comment about advances in rehabilitation medicine. Presentations include:

*Personalized Medicine as a Driver of Neuromuscular Care: Changing the Landscape by Tailoring Diagnostics and Treatment to the Individual Patient*
Friday, November 18 at 1:15 PM
Jeffrey Cohen, MD, Doug Elwood, MD and Swati Sathe, MD
This discussion will highlight how personalized medicine the use of genomic analysis to create individualized treatments for a patient and not just targeting the disease has revolutionized health care delivery and is now changing how physicians diagnose and manage genetic neuromuscular diseases such as Duchenne muscular dystrophy, spinal muscular atrophy and Pompe disease.

*TBI: Aging With a Chronic Disease*
Saturday, November 19 at 1:30 PM
Steven Flanagan, MD
This discussion offers rationale for treating traumatic brain injury (TBI) as a chronic disease with long-lasting medical problems requiring lifelong follow-up. Patients who suffer a TBI often exhaust the limited health care resources in the period soon after the initial injury resulting in inadequate long-term care.

*Using Advances in Technology to Improve Practice Management and Patient Care: Opportunities and Case Study*
Saturday, November 19 at 3:15 PM
Jeffrey Cohen, MD, Doug Elwood, MD and Jeffrey Heckman, DO
This presentation will highlight the integration of smartphones and tablet computers in a health care practice, discuss attitudes towards adoption of these tools by phy
'/>"/>

Contact: Craig Andrews
craig.andrews@nyumc.org
212-404-3511
NYU Langone Medical Center / New York University School of Medicine
Source:Eurekalert

0

GOOD

Page: 1 2

Related biology news :

1. Experts discuss climate change during UH lecture series
2. Experts to discuss global water crisis
3. More research needed to make good on biofuel promise, experts say
4. Experts agree: Environmental standards needed for biofuels
5. Kount Lands Veteran Fraud Experts From Retail Decisions and iovation
6. Experts agree: to protect the environment, biofuel standards are needed
7. Recommendations for childrens exercise lacking say experts
8. Innovations in Pediatric Medicine CME conference brings together national pediatrics experts
9. Innovations in Pediatric Medicine International Conference brings together pediatrics experts
10. NAS announces initiative to connect entertainment industry with top experts
11. Experts discuss applying systematic review to the field of nutrition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... (May 18, 2013) The AGA Research Foundation announced ... the relationship between the gut microbiota, one of today,s ... disease. , The AGA Research Awards Panel selected ... Massachusetts General Hospital and Harvard Medical School, Boston, as ... Dr. Chan will receive $25,000 of funding, commencing in ...
(Date:5/17/2013)... the interaction of a group of proteins in the ... identified a new target that could increase cell survival. ... School of Biochemistry and published in the EMBO ... eventually lead to new therapies for stroke and other ... by the team which identified a protein, known as ...
(Date:5/17/2013)... Bethesda, MD The Federation of American Societies for ... of National Institutes of Health (NIH) funding trends highlighting ... to support critical research. The FASEB analysis follows a ... Francis Collins, MD, PhD, who testified that the $1.6 ... to sequestration is "having a substantial impact on the ...
Breaking Biology News(10 mins):New gut microbiome research to explore red meat -- colorectal cancer pathway 2SUMO wrestling cells reveal new protective mechanism target for stroke 2
... 10, 2009)Attempts to treat critical limb ischemia in ... are still thwarted by restenosis (the re-narrowing of ... stenting), the need for repeat treatments and the ... death (gangrene) and amputation. Interventional radiologists have been ...
... Detects Faces in Motion, Matches with Watch-list ... Lithuania, March 9 Neurotechnology, a provider ... the availability of VeriLook Surveillance SDK, a ... using live video streams from high-resolution digital ...
... be tough, but scientists have found a Yellowstone National ... simple one-celled algae called Cyanidioschyzon -- thrives ... occurs naturally around hot springs, said Tim McDermott, professor ... at Montana State University. Cyanidioschyzon could ...
Cached Biology News:Promising 3-year data: Saving limbs with drug-eluting stents 2Promising 3-year data: Saving limbs with drug-eluting stents 3VeriLook Surveillance SDK Provides Real-Time Face Identification Using Video Surveillance Cameras 2VeriLook Surveillance SDK Provides Real-Time Face Identification Using Video Surveillance Cameras 3Montana State team finds Yellowstone alga that detoxifies arsenic 2Montana State team finds Yellowstone alga that detoxifies arsenic 3
(Date:5/21/2013)... Branchburg, NJ (PRWEB) May 21, 2013 ... enhancement industry, has appointed Dale Braddy to Southeastern USA ... proactively bolster its sales muscle in the Southeast. ... a food ingredient brokerage and supplier to food processors ... past 13 years in the food industry and has ...
(Date:5/21/2013)... As the R&D sector becomes ... the industry to deliver better products, faster. Collaborations ... companies often means turning big ideas into reality, ... collaboration with Sensidose AB and Recipharm, is one ... to market sooner. The partnership resulted in the ...
(Date:5/21/2013)... May 21, 2013  Synthetic Biologics, Inc. (NYSE MKT: SYN), ... of serious infectious diseases, announced today that Jeffrey ... Annual Marcum LLP MicroCap Conference on Thursday, May 30, ... the Grand Hyatt Hotel. Mr. Riley is scheduled to present ... of Synthetic Biologics, presentation can be accessed by logging onto ...
(Date:5/21/2013)... NANONEX CORPORATION, a pioneer and leading company ... successful delivery and installation of a new nanoimprint ... major Japanese manufacturing company. , ... lithography tool that has the ability to process ... types. Based on Nanonex inventions and proprietary technologies, ...
Breaking Biology Technology:The Development of an Innovative Microtablet Dosage Form, a Success Story: Live Webinar Hosted by Xtalks 2Synthetic Biologics to Present at the 2nd Annual Marcum LLP MicroCap Conference 2Nanonex Announces the Shipment and Installation of an Innovative Nanoimprint Lithography System for Fully Automated Manufacturing 2
... BOULDER, Colo., and IPSWICH, Mass., July 27, ... Biolabs, Inc. (NEB) announce today that they ... whereby SomaLogic will provide specific SOMAmers as ... and future NEB nucleic acid amplification and ...
... July 27, 2011 Cadence Pharmaceuticals, Inc. (NASDAQ: ... and commercializing proprietary products principally for use in the hospital ... ended June 30, 2011 financial results on Wednesday, August 3, ... call and live webcast to discuss the financial results on ...
... Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX ) today ... registration trial of KRX-0401 (perifosine) for the treatment of ... over 430 randomized patients, is being conducted pursuant to ... Drug Administration (FDA) and with Fast-Track Designation.  Perifosine is ...
Cached Biology Technology:Agreement Between SomaLogic and New England Biolabs Enables the Use of SOMAmer Technology for the Optimization of Multiple PCR Products 2Keryx Biopharmaceuticals Announces Completion of Patient Enrollment in KRX-0401 (Perifosine) Phase 3 Refractory Advanced Colorectal Cancer Study 2Keryx Biopharmaceuticals Announces Completion of Patient Enrollment in KRX-0401 (Perifosine) Phase 3 Refractory Advanced Colorectal Cancer Study 3Keryx Biopharmaceuticals Announces Completion of Patient Enrollment in KRX-0401 (Perifosine) Phase 3 Refractory Advanced Colorectal Cancer Study 4Keryx Biopharmaceuticals Announces Completion of Patient Enrollment in KRX-0401 (Perifosine) Phase 3 Refractory Advanced Colorectal Cancer Study 5